Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation; D016853:Muromonab-CD3; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3